Clinical Trial Update: Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating radiation therapy followed by Durvalumab and Tremelimumab plus surgery versus radiation therapy followed by surgery for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Durvalumab (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Hepatocellular Carcinoma (HCC) | Phase 3 | Status: NOT_YET_RECRUITING